InjectCo itemises what its monthly subscription buys down to the injection supplies and the training, and it names the pharmacy class it sources from. It also publishes two different monthly figures for the same compounded semaglutide programme on two of its own pages, and it serves one state.
What InjectCo charges
Semaglutide: $249/mo — per month on the service page; the seller's own weight-loss overview prices the same compounded semaglutide programme at $425 a month
Semaglutide: $425/mo — per month
Tirzepatide: $425/mo — per month; the page itemises medication, injection equipment, training, consultations, dose adjustments and delivery
InjectCo also sells 4 compounds this site boards without publishing a price for them: Sermorelin, NAD+, GHK-Cu and Glutathione.
InjectCo is not a paid partner; this link may earn a commission if that changes. Full disclosure.
By Nora Castellan, Standards EditorUpdated September 2026
Two prices for one programme, both live
Its compounded semaglutide service page prices the injectable programme at one monthly figure. Its own weight-loss overview page prices the compounded semaglutide programme at a considerably higher one.
Both pages were live on the same day, from the same seller, describing the same thing. Neither page acknowledges the other.
Both are recorded here and neither is picked. Until the seller reconciles them, a reader cannot know from the site which figure the checkout will apply.
An FDA-approval headline above compounded copy
Every compounded GLP-1 service page carries the headline "We Only Use FDA-Approved, Trusted Products" directly above copy describing compounded medicines.
Compounded medicines are not FDA-approved products; that is what compounding means. The seller's own sourcing sentence says the medication comes "through regulated pharmacy partners (licensed 503B pharmacy) and dispensed under applicable telemedicine and compounding regulations."
The headline is quoted here because it is what the page says. Nothing on this record credits it.
Five peptide pages with no peptide price
It publishes long dedicated pages for sermorelin, GHK-Cu, glutathione and NAD+ — tens of thousands of characters each.
None of them carries a figure for the compound it is about. The only numbers on those pages belong to a site-wide cosmetic promotion.
So the peptide catalogue reads as informational content, not as a price sheet. A reader who wants a peptide figure will have to ask for one.
One state, and the state is named
It is a Texas clinic. It publishes street addresses for locations in Plano and Austin and says virtual services are available statewide.
There is no multi-state claim anywhere, which at least means there is nothing overstated to check.
It also prices a sublingual semaglutide separately from the injection, and its tirzepatide page itemises medication, injection equipment, training, consultations, dose adjustments and delivery inside the one figure.
Who it's for
Texas readers who can use a clinic with physical addresses.
Buyers who want supplies, training and consultations itemised inside the price.
Shoppers comparing a sublingual option against an injection at one seller.
Readers who want the pharmacy class stated rather than left blank.
Who should look elsewhere
Anyone outside Texas.
Buyers who need one settled semaglutide figure before starting.
Readers looking for a published price on sermorelin, NAD+, GHK-Cu or glutathione.
Shoppers who want an accurate FDA statement on the page selling to them.
Strengths
Itemises what the monthly subscription buys, down to the injection supplies and the training
Prices a sublingual form separately from the injection
Names the pharmacy class — 503B — rather than leaving it unstated
Publishes street addresses for two physical clinics
Trade-offs
Publishes two different monthly figures for the same compounded semaglutide programme
Prints an FDA-approval headline above compounded product copy
Its five dedicated peptide pages carry no price for any peptide
Serves one state, so most readers cannot buy from it
How we verified this
Read the compounded semaglutide service page and the weight-loss overview page in the same session, confirmed both figures render, and recorded both without choosing.
Read the FDA-approval headline in its own context, directly above compounded product copy, and credited nothing from it.
Read all five dedicated peptide pages end to end and confirmed the only figures on them belong to a site-wide cosmetic promotion.
Requested a deliberately meaningless address on this host in the same session and confirmed it returns a not-found response.
Screened the brand against the live federal warning-letter table under two spellings, pulling all 3,677 records in pages and filtering locally because the table's own search parameter is ignored, with a positive and a nonsense control in the same run. No letter.
A provider to compare InjectCo against
Trellis Vitality
Trellis Vitality frames its program around body-composition tracking rather than scale weight, pairing NAD+, glutathione and tesamorelin with at-home biomarker panels and a 90-day re-test, and names its dispensing pharmacy, VialsRX in Houston, by address.
What does the semaglutide programme actually cost?
The site publishes two different monthly figures for it on two of its own pages, and reconciles neither. Both are recorded here. Confirm the figure before paying.
Is the medication FDA-approved?
Its pages carry a headline saying it only uses FDA-approved products, above copy describing compounded medicines, which are not FDA-approved. That headline is quoted here, not credited.
What does the peptide cost?
It does not say. Its dedicated sermorelin, NAD+, GHK-Cu and glutathione pages carry no price for those compounds at all.
Can I use it outside Texas?
Nothing on the site says so. It is a Texas clinic with two published addresses and says virtual services are available statewide, making no wider claim.
InjectCo is not a paid partner; this link may earn a commission if that changes. Full disclosure.